Rocket Lab
RKLB
$80.25
+0.19%
Rocket Lab Corporation is a vertically integrated space company that designs and manufactures the Electron and Neutron launch vehicles, the Photon satellite platform, and provides end-to-end mission services for civil, defense, and commercial markets. As a leading player in the small-launch segment, Rocket Lab differentiates itself through frequent, reliable launch access and a growing space systems business, positioning it as a key competitor to SpaceX in the commercial space race. The current investor narrative centers on the company's aggressive expansion into satellite manufacturing and services, highlighted by its recent $397 million Space Force contract and the acquisition of Iridium, which is expected to drive profitability by 2027. However, the stock has faced significant volatility due to concerns about the leveraged acquisition, Neutron rocket delays, and a high valuation, making it a battleground between growth optimists and risk-averse investors.…
RKLB
Rocket Lab
$80.25
Related headlines
Investment Opinion: Should I buy RKLB Today?
We rate RKLB a Hold. The consensus is Buy with an average target of $111.31, implying 47% upside, but the extreme valuation and execution risks temper enthusiasm. The thesis is that Rocket Lab's strong growth and government contracts justify a premium, but the current price already reflects much of the optimism.
Sign up to view all
RKLB 12-Month Price Forecast
The AI assessment is neutral with medium confidence. The company's exceptional growth is offset by an extreme valuation and lack of profitability. The stock is likely to remain volatile, with the outcome depending on execution. If the company delivers on its 2027 profitability target and Neutron succeeds, the stock could re-rate higher. However, any misstep could lead to a sharp decline. The stance would upgrade to bullish if the company achieves positive free cash flow earlier than expected, and downgrade to bearish if Neutron delays persist or revenue growth falls below 30%.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Rocket Lab's 12-month outlook, with a consensus price target around $112.76 and implied upside of +40.5% versus the current price.
Average Target
$112.76
0 analysts
Implied Upside
+40.5%
vs. current price
Analyst Count
—
covering this stock
Price Range
$64 - $150
Analyst target range
Rocket Lab is covered by 16 analysts, with a consensus recommendation of 'Buy' and a mean rating of 1.61 (where 1 is Strong Buy and 5 is Sell). The average target price is $111.31, implying an upside of approximately 47% from the current price of $75.67. The distribution shows a strong bullish tilt, with recent actions from firms like Craig-Hallum, Cantor Fitzgerald, and B of A Securities all maintaining Buy or Overweight ratings. However, the target range is wide, from a low of $64.00 to a high of $150.00, indicating significant uncertainty about the company's future performance. The high target of $150.00 assumes successful execution of the Neutron rocket and the Iridium integration, while the low target of $64.00 reflects concerns about delays and margin compression. The wide spread suggests that analysts are divided on the risk-reward profile, with some seeing substantial upside and others cautioning on valuation and execution risks.
Bulls vs Bears: RKLB Investment Factors
Rocket Lab presents a classic high-growth, high-risk investment. The bull case is anchored by exceptional revenue growth (63.5% YoY), major government contracts, and a clear path to profitability via Iridium. However, the bear case is equally compelling: a valuation at 61.5x sales, negative margins, and significant execution risks around Neutron and integration. Currently, the bear side has stronger evidence due to the extreme valuation and lack of profitability, but the bull case could quickly dominate if the company delivers on its 2027 profitability target. The single most important tension is whether Rocket Lab can execute on its growth plans without further delays or cost overruns, which would determine if the premium valuation is justified.
Bullish
- Revenue growth accelerating at 63.5% YoY: Q1 2026 revenue of $200.35M represents a 63.46% YoY increase, up from $122.57M in Q1 2025. Sequential growth from $179.65M in Q4 2025 to $200.35M in Q1 2026 shows accelerating demand, driven by space systems expansion.
- Major government contracts boost backlog: Rocket Lab secured a $397M Space Force contract and a $266M launch contract, its largest ever. These wins validate the company's credibility and provide multi-year revenue visibility, supporting the growth narrative.
- Analyst consensus is Buy with 47% upside: 16 analysts rate RKLB a Buy with a mean rating of 1.61 (Strong Buy to Buy). The average target price of $111.31 implies 47% upside from the current $75.67, reflecting optimism about future growth.
- Gross margin improving to 38.2%: Gross margin expanded to 38.18% in Q1 2026, up from 28.76% in Q1 2025. This trend indicates improving operational efficiency and a favorable mix shift toward higher-margin space systems.
Bearish
- Extreme valuation at 61.5x sales: The PS ratio of 61.51x is far above the aerospace & defense industry average of 2-3x. This premium leaves no room for error; any growth disappointment could trigger a severe de-rating.
- Negative profitability with -33% net margin: TTM net margin is -32.94%, and operating margin is -38.03%. The company is burning cash, with TTM free cash flow of -$316.3M, indicating reliance on external funding and a long path to profitability.
- High beta and extreme volatility: With a beta of 2.629, RKLB is highly sensitive to market swings. The stock has experienced a max drawdown of -60.99% and is down 28.25% over the past 3 months, reflecting significant risk.
- Neutron rocket delays and execution risk: The Neutron rocket, critical for future growth, has faced delays. The $397M Space Force contract hinges on successful Neutron launches, and any further slippage could damage credibility and backlog.
RKLB Technical Analysis
Rocket Lab's stock has exhibited a highly volatile and range-bound pattern over the past year, with a 71.59% gain over the last 12 months but a significant drawdown from its 52-week high of $151.00. As of August 6, 2026, the stock trades at $75.67, which is approximately 50% of its 52-week range (between $37.57 and $151.00), indicating it is closer to the lower end of its annual range. This positioning suggests that the stock has given back a substantial portion of its earlier gains, reflecting a market that is reassessing the company's growth prospects amid execution risks. The 1-year price change of +71.59% still shows a strong uptrend, but the current price near the midpoint of the range suggests a period of consolidation or potential trend reversal.
Beta
2.63
2.63x market volatility
Max Drawdown
-61.0%
Largest decline past year
52-Week Range
$38-$151
Price range past year
Annual Return
+87.5%
Cumulative gain past year
| Period | RKLB Return | S&P 500 |
|---|---|---|
| 1m | +5.3% | +2.9% |
| 3m | -35.7% | +5.0% |
| 6m | +19.0% | +13.9% |
| 1y | +87.5% | +20.4% |
| ytd | +5.6% | +13.8% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
RKLB Fundamental Analysis
Rocket Lab's revenue trajectory has been robust, with Q1 2026 revenue of $200.35 million, representing a 63.46% year-over-year growth rate. This growth is accelerating, as seen in the sequential increase from $179.65 million in Q4 2025 and $155.08 million in Q3 2025, indicating strong demand for launch services and space systems. The revenue breakdown shows Product revenue of $127.49 million and Service revenue of $72.86 million, with Product (likely spacecraft and components) driving the majority of growth. This trend underscores the company's successful expansion beyond launch services into higher-margin space systems, which is a key pillar of its long-term investment thesis.
Quarterly Revenue
$200348000.0B
2026-03
Revenue YoY Growth
+63.5%
YoY Comparison
Gross Margin
38.2%
Latest Quarter
Free Cash Flow
$-316301000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is RKLB Overvalued?
Given Rocket Lab's negative net income (TTM net margin of -32.94%), the price-to-sales (PS) ratio is the most appropriate valuation metric, as earnings-based multiples are not meaningful. The current PS ratio stands at 61.51x, which is extremely elevated compared to the broader aerospace & defense industry average of around 2-3x, indicating a massive premium. This premium reflects the market's high expectations for future growth, driven by the Iridium acquisition and government contracts, but it also leaves little room for error. The forward PE ratio of 9,084x, based on estimated EPS of $0.92, implies that the market expects profitability to materialize, but the current valuation already prices in a very optimistic scenario.
PE
-188.5x
Latest Quarter
vs. Historical
N/A
5-Year PE Range 17x~59x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-234.4x
Enterprise Value Multiple
Investment Risk Disclosure
Financial risks are substantial. Rocket Lab is unprofitable with a TTM net margin of -32.94% and operating margin of -38.03%. The company burned $316.3M in free cash flow over the TTM, indicating heavy reliance on capital markets. Debt-to-equity is 0.147, but the Iridium acquisition adds integration costs and potential dilution. Revenue concentration is a concern, as a significant portion comes from government contracts, which can be lumpy and subject to political changes. The company's current ratio of 4.08 provides liquidity, but continued cash burn could erode this buffer if growth stalls.